Blue Water Acquisition III Unit. (BLUWU) vs Scinai Immunotherapeutics (SCNI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLUWU | SCNI |
|---|---|---|
| Share price | $10.42 | $1.58 |
| Market cap | — | $1.04M |
| 1-day change | 0.00% | +1.66% |
| YTD return | -1.23% | — |
| P/E ratio (TTM) | — | 0.12 |
| EPS (TTM) | — | $13.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.31M |
| Revenue growth (YoY) | — | +99.24% |
| Net income (latest FY) | $4.67M | $-8.31M |
| Gross margin | — | -202.29% |
| Operating margin | — | -575.29% |
| Net margin | — | -633.64% |
| 52-week high | $12.85 | $52.00 |
| 52-week low | $0.00 | $1.13 |
| Distance from 52-week high | -18.91% | -96.96% |
| Average volume | 45 | 576.34K |
| Shares outstanding | — | 657.61K |
| Employees | — | 45 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Blue Water Acquisition III Unit.
BLUWU stock →Blue Water Acquisition Corp. III does not have significant operations.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
About Scinai Immunotherapeutics
SCNI stock →Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 45 employees
BLUWU vs SCNI FAQ
Are Blue Water Acquisition III Unit. and Scinai Immunotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.